CAD 0.1
(-4.76%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -20.28 Million CAD | -26.4% |
2022 | -16.04 Million USD | -67.7% |
2021 | -9.56 Million CAD | 90.62% |
2020 | -101.99 Million CAD | -1106.4% |
2019 | -8.45 Million CAD | 58.77% |
2018 | -20.5 Million CAD | -16102.25% |
2017 | -126.54 Thousand USD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 Q4 | -4.33 Million USD | 47.85% |
2023 FY | - CAD | -26.4% |
2023 Q1 | -3.56 Million USD | 36.86% |
2023 Q2 | -4.14 Million USD | -16.28% |
2023 Q3 | -8.3 Million CAD | -100.52% |
2022 Q3 | -2.67 Million USD | 34.11% |
2022 FY | - USD | -67.7% |
2022 Q1 | -3.98 Million USD | -120.08% |
2022 Q2 | -4.06 Million USD | -1.91% |
2022 Q4 | -5.64 Million USD | -110.88% |
2021 Q1 | -142.74 Thousand CAD | 78.35% |
2021 Q4 | -1.81 Million CAD | 16.97% |
2021 Q3 | -2.18 Million CAD | 62.12% |
2021 Q2 | -5.75 Million CAD | -3932.25% |
2021 FY | - CAD | 90.62% |
2020 Q1 | -3.66 Million CAD | -45.01% |
2020 FY | - CAD | -1106.4% |
2020 Q4 | -659.26 Thousand CAD | 93.48% |
2020 Q3 | -10.11 Million CAD | 88.12% |
2020 Q2 | -85.14 Million CAD | -2222.92% |
2019 Q2 | -2.96 Million CAD | 2.47% |
2019 Q1 | -3.04 Million CAD | 17.23% |
2019 Q3 | 137.79 Thousand CAD | 104.64% |
2019 FY | - CAD | 58.77% |
2019 Q4 | -2.52 Million CAD | -1934.29% |
2018 Q4 | -3.67 Million CAD | 14.03% |
2018 Q2 | -7.9 Million CAD | 0.0% |
2018 Q1 | - USD | 100.0% |
2018 Q3 | -4.27 Million CAD | 45.89% |
2018 FY | - CAD | -16102.25% |
2017 FY | - USD | 0.0% |
2017 Q4 | -10.54 Thousand USD | 99.2% |
2017 Q1 | -20 Thousand USD | 0.0% |
2017 Q2 | -1.79 Million CAD | -8859.88% |
2017 Q3 | -1.31 Million CAD | 26.42% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Aion Therapeutic Inc. | -6.07 Million CAD | -233.905% |
Ayurcann Holdings Corp. | -2.01 Million CAD | -908.728% |
Blueberries Medical Corp. | -1.22 Million CAD | -1559.893% |
The BC Bud Corporation | -1.19 Million CAD | -1595.665% |
BioNxt Solutions Inc. | -6.48 Million CAD | -212.746% |
CordovaCann Corp. | -1.6 Million CAD | -1165.454% |
Christina Lake Cannabis Corp. | -2.62 Million CAD | -673.042% |
Captor Capital Corp. | 2.42 Million CAD | 937.628% |
City View Green Holdings Inc. | -2.01 Million CAD | -906.74% |
1CM Inc. | 1.31 Million CAD | 1643.966% |
Global Hemp Group Inc. | -24.79 Thousand CAD | -81698.855% |
Greenway Greenhouse Cannabis Corporation | -2.2 Million CAD | -818.332% |
IM Cannabis Corp. | -2.79 Million CAD | -626.896% |
Lobe Sciences Ltd. | -4.4 Million CAD | -360.678% |
Maple Leaf Green World Inc. | -392.21 Thousand CAD | -5070.72% |
Mountain Valley MD Holdings Inc. | -3.19 Million CAD | -535.152% |
Nextleaf Solutions Ltd. | 1.14 Million CAD | 1876.487% |
Ovation Science Inc. | -778.83 Thousand CAD | -2503.949% |
Pharmadrug Inc. | -1.33 Million CAD | -1419.116% |
Captiva Verde Wellness Corp. | -6.05 Million CAD | -234.877% |
RAMM Pharma Corp. | -6.3 Million CAD | -221.804% |
Revive Therapeutics Ltd. | -5.59 Million CAD | -262.473% |
Red White & Bloom Brands Inc. | -77.59 Million CAD | 73.863% |
SLANG Worldwide Inc. | -2.95 Million CAD | -587.304% |
1933 Industries Inc. | -10.03 Million CAD | -102.138% |
Red Light Holland Corp. | -5.25 Million CAD | -285.863% |
Top Strike Resources Corp. | -767.99 Thousand CAD | -2540.7% |
Xebra Brands Ltd. | -1.49 Million CAD | -1256.551% |
Adastra Holdings Ltd. | -1.41 Million CAD | -1337.037% |